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Abstract  
Background and Objective Although metabolite-to-parent drug concentration ratios in hair have 
been suggested as a possible tool to study the metabolism of drugs in a non-invasive way, no studies 
are available that evaluate this in a systematic way. Cytochrome P450 (CYP) 1A2 is a drug 
metabolizing enzyme characterized by large inter-individual differences in its activity. The standard 
approach for CYP1A2 phenotyping is to determine the paraxanthine/caffeine ratio in plasma, at a 
fixed time point after intake of a dose of the CYP1A2 substrate caffeine. The aim of this study was to 
evaluate whether paraxanthine/caffeine ratios measured in hair samples reflect the plasma-based 
CYP1A2 phenotype.  
Methods  Caffeine and paraxanthine concentrations were measured in proximal 3-cm 
segments of hair samples from 60 healthy volunteers and resulting paraxanthine/caffeine ratios were 
correlated with CYP1A2 phenotyping indices in plasma. 
Results   Paraxanthine/caffeine ratios in hair ranged from 0.12 to 0.93 (median 0.41), 
corresponding ratios in plasma ranged from 0.09 to 0.95 (median 0.40). A statistically significant 
correlation was found between ratios in hair and plasma (r = 0.41, p = 0.0011). However, large 
deviations between ratios in both matrices were found in individual cases. Although the influence of 
several factors on paraxanthine/caffeine ratios and hair-plasma deviations was investigated, no 
evident factors explaining the observed variability could be identified. 
Conclusion The variability between hair and plasma ratios complicates the interpretation of hair 
ratios on an individual basis and, therefore, compromises their practical usefulness as alternative 
CYP1A2 phenotyping metrics. 
 Key Points 
 For the first time, the usefulness of paraxanthine/caffeine molar concentrations ratios 
in hair for CYP1A2 phenotyping was evaluated by comparing hair ratios from 60 
healthy volunteers with reference, plasma-based CYP1A2 phenotyping indices . 
 Although ratios in hair and plasma showed a statistically significant correlation, large 
deviations were found in individual cases. Investigating the influence of several 
factors did not provide a clear explanation for the observed deviations, complicating 
the interpretation of hair ratios on an individual basis.
 1 Introduction 
Sampling and analysis of hair has earned an established place in bioanalysis, with applications in 
diverse fields, including, amongst others, postmortem toxicology, workplace drug testing, doping 
control, driving ability examination and detection of pre- and postnatal drug exposure. Owing to the 
ability to retrospectively determine drug use over a time window of several months (or even years), 
together with the long-term stability of many drugs in hair and the non-invasive sample collection, 
hair strands are collected as an alternative for, or in combination with, traditional blood or urine 
samples. On the other hand, important limitations associated with hair analysis are the lack of a 
clear-cut correlation between hair and plasma concentrations -the latter reflecting drug dose- for 
many substances and the risk of misinterpreting hair results due to external contamination [1,2]. 
In addition to the determination of parent drugs, highly sensitive analytical techniques, such as liquid 
chromatography (LC)- or gas chromatography (GC)-tandem mass spectrometry (MS/MS), also allow 
to quantity specific drug metabolites in hair, which are often present at low concentration levels. 
Resulting metabolite-to-parent drug concentration ratios have been applied to distinguish active 
ingestion of a drug from external contamination or passive exposure. For this purpose, cut-off values 
have been proposed for several drugs, such as cocaine, heroin and tramadol [3,4]. Apart from the 
latter application, the use of metabolite-to-parent drug concentration ratios in hair has recently been 
proposed as a possible means to assess the metabolic phenotype of drug metabolizing enzymes, as 
reviewed by De Kesel et al. [5]. Thieme et al. found that nortriptyline/amitriptyline concentration 
ratios measured in hair samples of children (n = 23) correlated significantly with the number of 
functional alleles of CYP2C19, the enzyme that is predominantly responsible for the demethylation of 
amitriptyline. Poor metabolizers showed significantly lower nortriptyline/amitriptyline ratios in hair 
compared to intermediate or rapid extensive metabolizers [6]. Eisenhut et al. determined 
concentrations of the anti-tuberculosis drug isoniazide and its metabolite acetylisoniazide in hair 
samples (n = 24) and correlated the corresponding metabolite-to-parent drug concentration ratios to 
the arylamine N-acetyltransferase-2 (NAT-2) genotype. Acetylisoniazide/isoniazide ratios in hair 
samples of slow acetylators were significantly lower than ratios in subjects possessing rapid 
acetylator genotypes [7]. In a recent study, LeMasters et al. found higher cotinine levels in hair of 
secondhand smoke exposed children carrying the NAT-1 minor allele compared to children with the 
major allele [8]. Several groups also reported on the use of metabolite-to-parent drug ratios to 
(retrospectively) detect changes in drug metabolism within individuals during pregnancy. Koren et al. 
found higher cotinine/nicotine ratios in hair segments corresponding to the third trimester of 
pregnancy than in segments corresponding to the first trimester, as determined in hair samples of 74 
pregnant women. According to the authors, these results suggest an increased CYP2A6-mediated 
nicotine metabolism during pregnancy [9]. Similar findings for the antidepressant citalopram and its 
metabolite norcitalopram, determined in hair samples of 4 subjects, were described by O’Brien et al. 
[10]. Finally, by analyzing proximal hair segments from 29 women involved in a methadone-assisted 
therapy at different time points during pregnancy, Himes et al. found a positive correlation between 
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)/methadone ratios and cumulative 
methadone dose. Also here, the authors suggested that these findings could indicate an altered 
metabolism during gestation [11]. Although the above mentioned results seem very promising, it 
should be noted that in the latter 3 studies no control samples from non-pregnant women or 
reference phenotyping indices determined in non-hair matrices were included to support the validity 
of hair ratios in reflecting changes in drug metabolism. 
The aim of this study was to evaluate the usefulness of determining paraxanthine/caffeine 
concentration ratios in hair for CYP1A2 phenotyping by comparing hair ratios of healthy volunteers 
with their reference, plasma-based CYP1A2 phenotyping indices. CYP1A2, a member of the CYP 
family of drug metabolizing enzymes, plays a role in approximately 9 % of drug metabolism pathways 
in which CYP isoforms are involved [12]. Several therapeutically used drugs are metabolized by 
CYP1A2, including olanzapine [13], clozapine [14], zolmitriptan [15] and warfarin [16]. CYP1A2 
activity is affected by a combination of genetic, nongenetic and environmental factors [12] and, 
consequently, its activity displays a high inter-individual variability [17]. Therefore, a phenotyping 
approach involving controlled administration of a selective probe drug is preferred to assess CYP1A2 
activity. As caffeine is predominantly metabolized by CYP1A2, it is the probe drug of choice [17,18]. 
In typical phenotyping approaches the paraxanthine/caffeine concentration ratio is determined 4-6 h 
post-administration in serum or plasma samples [19], although dried blood spots [20] and saliva [21] 
have proven to be appropriate matrices for this purpose as well. A CYP1A2  phenotyping procedure 
based on hair analysis would eliminate the need to administer a caffeine test dose, since it is 
expected that caffeine and paraxanthine will readily be detected in hair samples of a large part of the 
population given the widespread consumption of caffeine-containing beverages (e.g. coffee, tea, soft 
drinks) and food products (e.g. chocolate). Our study is the first to compare hair ratios with plasma 
ratios for phenotyping purposes. The comparison between paraxanthine/caffeine ratios in hair and 
those obtained using a classical plasma-based approach may provide valuable insights into the 
usefulness and potential of hair analysis for this purpose. This could e.g. be relevant in fatal cases 
where it might be possible to deduce a phenotype postmortem by analyzing hair. 
2 Methods 
2.1 CYP1A2 phenotyping study 
A CYP1A2 phenotyping study involving healthy volunteers was approved by the Ethics Committee of 
Ghent University Hospital (B670201111655). Scalp hair samples were collected at the posterior 
vertex region after obtaining written informed consent from each participant. Caffeine and 
paraxanthine concentrations were determined in proximal 3-cm segments and the corresponding 
paraxanthine/caffeine molar concentration ratios were calculated. For 4 volunteers, a segmental 
analysis of 6 consecutive 3-cm hair segments was performed as well.  At the day of hair sampling, a 
standard CYP1A2 phenotyping procedure was conducted in the same study population, as described 
elsewhere [20]. Briefly, caffeine and paraxanthine concentrations were determined with a validated 
method in plasma samples from volunteers that had taken a 150 mg caffeine capsule 6 hours (± 5 
minutes) before sample collection [20,22]. By means of a written questionnaire, data on sex, age, 
general health status, smoking habits, caffeine intake, alcohol consumption, intake of drugs 
(including hormonal contraception) and cosmetic hair colouring were obtained. Caffeine intake was 
defined as the number of caffeine-containing drinks (including coffee, tea, soft and energy drinks) 
per day, while alcohol use was defined as the number of alcohol-containing drinks per week. 
Volunteers were asked to report chronic and occasional medication use at the time of inclusion and 
in the past without defining a time frame. A list of substrates, inhibitors or inducers of CYP1A2 was 
not available. Hair color was assessed by visual inspection of the collected samples in the laboratory. 
2.2 Hair sample collection, pretreatment and analysis 
Hair locks were cut as close as possible to the scalp at the posterior vertex region of the head and 
stored in aluminum foil envelopes at room temperature until analysis. Using adhesive tape, hair 
samples were either segmented into 3-cm sections or only the proximal 3-cm segment was used. The 
resulting segments were decontaminated in methylene chloride (20 mL, 2 min), followed by two 
washes in water (20 mL, 2 min). Following each wash step, the wash solvents were removed and the 
hair was air-dried. Dried samples were cut into small snippets (< 5 mm) using scissors before being 
manually ground in a mortar with liquid N2. One mL of a solution of protease type VIII (1.2 IU/mL) in 
Tris buffer (pH 7.5, 50 mmol/L), containing the internal standards caffeine-13C3 and paraxanthine-
13C4-15N3, was then added to 20 mg of ground hair. The samples were shaken for 1 hour at 37 °C and 
750 rpm and centrifuged for 10 minutes at 10000 x g. Subsequently, the supernatants were cleaned-
up by solid phase extraction (SPE) using Phenomenex Strata-X™ cartridges (200 mg, 3 mL). These were 
conditioned and equilibrated with 3 mL of methanol and 2 mL of water, respectively, prior to 
application of the hair extracts. The cartridges were washed with 2 mL of a water/methanol mixture 
(65/35, v/v) and dried for 2 minutes. The analytes were eluted from the columns with 4 × 500 µL of a 
methanol/acetonitrile mixture (50/50, v/v). The obtained solutions were evaporated under a stream 
of N2 and redissolved in 150 µL of the mobile phase. Data on the optimization of the hair extraction 
procedure are described elsewhere [De Kesel et al., submitted]. 
To evaluate the effect of the analytical wash procedure, the second (i.e. 3-6 cm) segments of 10 
samples from the data set were decontaminated and all wash solvents were subsequently analyzed. 
The samples originated from 5 individuals with the largest positive differences between hair and 
plasma ratios and 5 individuals with the largest negative differences (see further). 
All analyses were performed on an LC-MS/MS configuration consisting of a Waters Acquity UPLC® 
system (Waters, Milford, MA, USA) and an AB SCIEX API 4000™ triple quadrupole mass spectrometer 
(AB SCIEX, Framingham, MA, USA), controlled by AB SCIEX Analyst 1.5.2 and Waters Acquity console 
software. Chromatographic conditions for the determination of caffeine and paraxanthine in hair 
were identical to those previously described for the analysis of dried blood spots, whole blood and 
plasma [22]. The same holds for the API 4000™ mass spectrometer parameters, except for some 
minor modifications [De Kesel et al., submitted]. All compounds were detected in scheduled multiple 
reaction monitoring (sMRM) mode. The monitored precursor to product ion transitions were 
identical as previously described [22]. 
Validation of the hair analysis procedure was based on U.S. Food and Drug Administration (FDA) and 
European Medicines Agency (EMA) guidelines for bioanalytical method validation [23,24]. For both 
compounds, no carry-over or interferences were seen in the chromatogram. Linear calibration curves 
for caffeine and paraxanthine ranged from 20 to 500 pg/mg, with 20 pg/mg being the lower limit of 
quantification (LLOQ) for both compounds. Intra- and interbatch precision was below 12% (% relative 
standard deviation, %RSD) and accuracy below 7% (%bias) for all QCs (20, 60, 200 and 400 pg/mg). 
Matrix effects were determined at two concentrations levels using hair samples from five different 
individuals. Ion suppression was observed for caffeine (56.58 – 66.24 % absolute matrix effect) and 
paraxanthine (79.70 – 81.16 % absolute matrix effect). When compensation by the IS was taken into 
account, absolute matrix effects approximated 100 % and relative matrix effects were within 15 % 
limits. The same five hair samples were used to determine the recovery of the sample preparation 
procedure by spiking samples before and after extraction and clean-up. Recovery was high (> 87 %) 
and reproducible (%RSD < 15 %). Incurred and processed samples were stable under the evaluated 
conditions. Finally, it was shown that extracts of hair samples could be safely diluted 5-fold. Full 
details on the validation of the hair method are described elsewhere [De Kesel et al., submitted]. 
2.3 Chemicals and stock solutions 
Ultrapure water was obtained from a Synergy® Water Purification System (Merck Millipore, Overijse, 
Belgium). Methanol, acetonitrile and methylene chloride were purchased from Biosolve 
(Valkenswaard, The Netherlands). Caffeine, caffeine-13C3, paraxanthine, paraxanthine-13C4-15N3, 
theophylline, theobromine, formic acid, proteinase K, protease type VIII, protease type XIV, 
dithiothreitol and trishydroxymethylaminomethane (Tris) were all purchased from Sigma-Aldrich 
(Diegem, Belgium). HCl (1N) was obtained from Merck KGaA (Darmstadt, Germany) and liquid N2 
from Air Liquide (Brussels, Belgium). Stock solutions were prepared as described elsewhere [22]. 
2.3.1 Statistical analysis 
Statistical evaluation and graphical representation of the data was performed using Microsoft Excel® 
2010 (Microsoft, Redmond, WA, USA), IBM SPSS Statistics 20 (IBM Corp., Armonk, NY) and Medcalc 
12.7.5 (MedCalc Software bvba, Ostend, Belgium). Normality of paraxanthine/caffeine ratios in 
plasma and hair was assessed by Kolmogorov-Smirnov test.  Correlation was examined by Pearson 
coefficient of correlation. Differences between 2 groups were determined by independent samples t-
tests, while one-way analysis of variances (ANOVA) and Tukey post-hoc tests were used when more 
than 2 groups were compared. Significance was defined as p < 0.05. 
3 Results 
Caffeine and paraxanthine concentrations in 6 consecutive 3-cm hair segments from 4 female, 
healthy volunteers overall decreased with increasing distance from the hair root (Figure 1 a-d). 
Corresponding paraxanthine/caffeine molar concentration ratios showed a considerable variability 
between the consecutive hair segments (Figure 1 e). Therefore, we decided to analyze proximal 3-cm 
hair segments in the actual comparative phenotyping study.  
Paraxanthine was not detected in any of the analyzed wash solvents. For caffeine, responses below 
the LLOQ were seen in all wash solutions from all 10 participants of the phenotyping study. Although 
no real quantitative conclusions can be drawn from these data, peak areas were compared with the 
peak area of the LLOQ. The average peak area of caffeine was 54.08 ± 10.16 % of the LLOQ for the 
methylene chloride wash, 39.80 ± 11.44 % for the first water wash and 21.46 ± 6.10 % for the second 
water wash. 
Sixty healthy volunteers were involved in the CYP1A2 phenotyping study, including 43 women and 4 
smokers. The age of the participants ranged from 24 to 48 years (mean ± standard deviation (SD); 
28.8 ± 5.7). Paraxanthine/caffeine molar concentration ratios in plasma and hair samples were 
normally distributed (Kolmogorov-Smirnov test; p = 0.200 and p = 0.093, respectively). The median 
paraxanthine/caffeine ratios in both matrices, along with the measured ranges, are listed in Table 1. 
Pearson correlation analysis revealed a correlation coefficient of 0.410 for ratios in hair and plasma 
(p = 0.001). Although the correlation was found to be statistically significant, a wide scatter of the 
data was observed, with large deviations between corresponding ratios in hair and plasma in 
individual cases (Figure 2). To evaluate further into depth to what extent ratios in hair correlate with 
corresponding plasma-based ratios, the datasets from both matrices (n = 60) were sorted from low 
to high and arbitrarily divided into 3 equally-sized groups (n = 20 for each group). From the 20 
individuals showing the lowest ratios in plasma, 12 also showed the lowest ratios in hair, 6 were in 
the intermediate subgroup and 2 were in the subgroup with the highest ratios in hair (Figure 3 a). A 
similar pattern was observed for the 20 individuals showing the highest ratios in plasma: 12 subjects 
were in the subgroup with the highest ratios in hair, while 5 were in the intermediate subgroup and 3 
were in the subgroup with the lowest ratios in hair (Figure 3 b).  
The influence of various factors, both related to the use of hair as a bioanalytical matrix and to a 
possible effect on CYP1A2 activity, was evaluated. The median values and corresponding ranges for 
paraxanthine/caffeine ratios in plasma and hair are listed in Table 1. Hair color had no apparent 
effect on the paraxanthine/caffeine ratios. Ratios in plasma as well as in hair did not differ 
significantly between individuals with non-cosmetically-treated blond, brown, dark or black hair (p = 
0.836 and 0.708, respectively). In addition, paraxanthine/caffeine ratios in subjects with cosmetically 
coloured hair were compared with ratios from subjects with non-cosmetically treated hair. Again, no 
significant differences were found for the ratios in both plasma and hair (p = 0.941 and 0.959, 
respectively). Concerning the effect of factors affecting CYP1A2 activity, we found that hormonal 
contraception users had 1.7-fold lower paraxanthine/caffeine ratios in plasma compared with 
women not taking hormonal contraception (p < 0.0001). Although also in hair the median ratio was 
lower in hormonal contraception users, this difference did not reach statistical significance when 
comparing hormonal contraception users and non-users (p = 0.143). Apart from hormonal 
contraceptives, none of the participants reported the use of any drugs that interfere with CYP1A2 
activity. Both in plasma and hair, women showed lower ratios compared to men (p = 0.00136 and 
0.0465, respectively); however, this sex effect disappeared when hormonal contraception users were 
excluded (p = 0.317 and 0.412 for plasma and hair, respectively). Paraxanthine/caffeine ratios in the 
small subgroup of smokers (n = 4) were not significantly different from ratios in non-smokers (p = 
0.119 and 0.274 for plasma and hair, respectively). Also average caffeine intake had no apparent 
effect on measured ratios (p = 0.154 and 0.915 for different groups of caffeine intake in plasma and 
hair, respectively). Yet it is interesting to note that hair caffeine concentrations actually showed an 
increasing trend in subjects consuming higher amounts of caffeine, with significantly higher 
concentrations in hair from subjects reporting intake of > 7 caffeine consumptions/day (p < 0.0001) 
(Supplementary Figure S1). Concerning the influence of alcohol intake, individuals not consuming 
alcohol showed higher paraxanthine/caffeine ratios in plasma compared to individuals consuming 1-
3 consumptions/week (p = 0.031). However, again, the difference was no longer significant when 
excluding hormonal contraception users from the comparison (p = 0.629). Finally, we found no effect 
of age on paraxanthine/caffeine ratios (p = 0.343 and 0.880 for plasma and hair, respectively).  
To further investigate the effect of these factors on the variability between ratios in hair and plasma, 
2 subgroups (n = 15) were selected from the dataset, with either a good or a poor correlation 
between ratios in hair and plasma (Figure 2), with respective differences between corresponding 
ratios below 15 % and above 60 %. The distribution of all groups of participants in the poor and good 
correlation subgroup, as well as in the entire dataset, is displayed in Figure 4. For none of the 
evaluated factors, a clear effect on the variability between hair and plasma ratios was found as the 
distribution in both subgroups was similar in all cases.  
4 Discussion 
Determining metabolite-to-parent drug concentration ratios in traditional matrices, such as plasma 
or urine [19], or alternative samples, such as dried blood spots [20] or saliva [21] is an accepted 
approach to assess the metabolic activity of enzymes. In the last few years, the use of hair analysis 
has been introduced in this field [5]. Already in 1996, Mizuno et al. suggested the use of the caffeine 
content in hair as an indicator of liver function, as they found higher caffeine concentrations in hair 
of liver cirrhosis patients compared to healthy volunteers [25]. In this study, using an optimized and 
validated LC-MS/MS method, paraxanthine/caffeine concentration ratios were determined in hair for 
the first time as a potential measure of CYP1A2 activity. This is, to the best of our knowledge, the first 
study in which metabolite-to-parent drug ratios in hair were compared with reference, plasma-based 
phenotyping metrics.   
Segmental hair analysis showed decreasing caffeine and paraxanthine concentrations from the hair 
root to the distal end. As all 4 volunteers reported to generally have a constant caffeine intake over 
time and none of the hair samples had been cosmetically treated (i.e. coloured, bleached or 
permed), the observed decrease in analyte concentrations along the hair shaft is probably due to a 
wash-out effect caused by regular hair washing, mechanical stress and influence of UV-light over 
time [1]. Although the underlying reason for the observed variability between paraxanthine/caffeine 
ratios is not known, we cannot exclude the theoretical possibility that caffeine and paraxanthine 
might be unequally removed from the hair as a result of regular hair washing or other environmental 
factors to which hair is exposed over time, which could affect paraxanthine/caffeine ratios. Data on 
hair washing habits were not collected, as it would be very difficult to adequately assess the effect of 
these factors, given the large variability in regular hair washing procedures that can be expected. As a 
result, proximal 3-cm hair segments were used in this study, as is also commonly applied when 
determining markers of alcohol use in hair [26]. Furthermore, from a practical point of view, 
analyzing the first 3-cm segment was more convenient as it allowed to apply the procedure to 
individuals with short hair as well, thereby preventing that hair length would be a limiting factor for 
inclusion in the study. Although 3-cm segments could be obtained from all participants, hair length 
would be even less of a concern when shorter segments were used. However, this was not an option 
in this study for two reasons. First, we wished to avoid that samples needed to be excluded from the 
study due to limited sample amount (i.e. less than 20 mg of ground hair) or measured concentrations 
below the LLOQ, especially for the metabolite paraxanthine which was expected to be present in hair 
at lower concentrations. Second, while the aforementioned sensitivity issue might be coped with by 
sampling a shorter segment from a larger head area, this would undoubtedly have had a negative 
cosmetic impact, rendering it difficult to recruit sufficient volunteers. 
Using data from 60 healthy volunteers, a statistically significant correlation between ratios in hair 
and plasma was found, albeit that large deviations were observed for some individuals. Given the 
lack of a clear link between CYP1A2 activity and known polymorphisms of the CYP1A2 gene, a 
distinction between poor or extensive metabolizer status, as is the case for other CYP450 isoforms 
such as CYP2D6, cannot be made for CYP1A2 [12,27]. In addition, there are also no established 
reference ranges or cut-off values for CYP1A2 phenotyping metrics available. In this light, Figure 3 
illustrates to what extent ratios in hair correlate with corresponding plasma-based ratios. This 
graphical representation shows that, in some cases, ratios in hair do not provide a reliable reflection 
of the CYP1A2 activity. For example, 3 individuals (2 women, 1 men) belonging to the subgroup of 
participants with the highest ratios in plasma, showed hair ratios that were among the 5 lowest 
measured in the entire study population (Figure 3 b). As described below, the effect of several 
variables was evaluated for these individuals, as was done for the entire data set. They were non-
smokers, had different hair color and did not report cosmetic hair colouring, use of CYP1A2-affecting 
medication, excessive caffeine or alcohol intake. Therefore, no clear explanation for their deviating 
results was available.   
In general, many factors may contribute to the observed deviations between ratios in hair and 
plasma. We consider it most unlikely that analytical issues contributed to the observed variability. 
Validated LC-MS/MS methods were used for both matrices, with highly comparable data for 
precision (%RSD) and accuracy (%bias) in hair [De Kesel et al., submitted] and plasma [22]. In 
addition, the differences between hair and plasma ratios cannot be explained by breakdown of the 
analytes during storage, as caffeine and paraxanthine were stable in hair stored at room temperature 
for at least 644 days [De Kesel et al., submitted] as well as in plasma stored at -20 °C for at least 172 
[22]. Our evaluation of the analytical wash procedure only demonstrated the presence of caffeine in 
the wash solvents, with peak areas corresponding to less than 30 % of the LLOQ in the last wash step, 
consistent with our observations in the validation of this procedure [De Kesel et al., submitted]. In 
general, these amounts will have a limited impact on measured paraxanthine/caffeine ratios. 
Another aspect that may have an effect on the observed variability is the methodological nature of 
the conducted comparative phenotyping study. Paraxanthine/caffeine ratio determined in plasma 
samples represent a measure of the CYP1A2 activity at the actual time of sampling. Ratios measured 
in 3-cm hair segments, on the other hand, rather may provide an image of the enzyme activity over a 
period of approximately 3-4 months prior to sampling, assuming that it takes approximately 2 weeks 
until a hair reaches the scalp and that hair grows with an average rate of 1.06 cm/month [28]. As a 
consequence, high intra-individual variability in CYP1A2 activity over time might be raised as an 
explanation for the differences between ratios in hair and plasma. However, using a similar CYP1A2 
phenotyping approach as applied here, Simon et al. found that paraxanthine/caffeine ratios, 
determined in plasma 5 hours after administration of a 140 mg caffeine dose, did not differ 
significantly over a period of 12 weeks. The authors reported an intra-individual coefficient of 
variation (CV) of 17.6 ± 6 % and 16.2 ± 5.9 %, respectively in young and elderly subjects [29]. Based 
on the findings from this study, combined with the fact that none of the volunteers in our study 
reported to take (or have taken) medication of which an inhibiting or inducing effect on CYP1A2 has 
been described (apart from hormonal contraception), we consider it unlikely that intra-individual 
variability can explain the observed deviations.  
In addition to the factors described above, the incorporation of caffeine and paraxanthine in hair 
may be a matter of concern. Incorporation of analytes into hair is a complex phenomenon in which 
multiple mechanisms are involved. Compounds can be incorporated via passive diffusion from blood 
capillaries or other tissues surrounding the hair follicle, from sweat or sebum or through external 
contamination [30]. Many factors affect these processes, such as the physicochemical properties of 
the analyte and its affinity for binding to melanin in hair. As melanin determines hair pigmentation, a 
color-dependent incorporation has been described for several compounds [31,32]. Here, no 
influence of hair color on paraxanthine/caffeine ratios was found. Furthermore, it is known that 
cosmetic treatment of hair may decrease drug concentrations [33]. However, in our population, 
cosmetic hair colouring did not affect measured ratios in hair. In addition, both factors had no 
apparent effect on the observed hair-plasma deviations. Another aspect that may play a role is the 
site of hair sampling. Dussy et al. determined caffeine concentrations in hair locks from 3 individuals 
collected at 10 different areas of the scalp. Coefficients of variation of measured caffeine 
concentrations ranged from 12.6 to 61.9 %, while a CV of 4.5 % was found for a homogenized control 
sample analyzed in six-fold [34]. However, it should be noted that the areas of sampling were widely 
distributed over the scalp, which could have contributed to the observed variability in measured 
concentrations as the proportions of hair in the anagen or telogen phase may vary in function of the 
location. In our study, all hair samples were cut from the posterior vertex region of the head. It is 
generally recognized that the proportion of hair in the telogen phase is the lowest and that hair 
growth rate shows less variability in this region [1,2]. Furthermore, all samples were collected by the 
same operator to minimize variation in the actual sampling site. 
As mentioned in the introduction section, CYP1A2 activity is characterized by a large inter-individual 
variability to which many factors have been reported to contribute. The influence of several factors 
on CYP1A2 activity was evaluated. The inhibiting effect of hormonal contraceptives found in our 
population is similar to that described in other studies [35,36]. When hormonal contraception users 
were excluded, no sex differences in paraxanthine/caffeine ratios were found. This is in agreement 
with other studies in which sex was found not to influence CYP1A2 activity [29,35]. Furthermore, an 
inducing effect of smoking [29,35,36] or caffeine consumption [35,36] was not observed in our study. 
However, as our study population contained only 4 smokers and 4 individuals reporting intake of > 7 
caffeine consumptions/day, we might have been unable to detect an existing effect of these factors. 
In accordance with other studies [29,36], we also found no effect of age on paraxanthine/caffeine 
ratios. Finally, none of the above-mentioned factors could explain the variability between ratios in 
hair and plasma. However, it should be noted that subdividing the data set (n = 60) into different 
subgroups resulted in small (or, in some cases, very small) group sizes. Consequently, some statistical 
comparisons may be underpowered. Future studies with even more participants or with participants 
belonging to certain focus groups (e.g. more smokers) may be needed to make more conclusive 
statements. 
5 Conclusion 
In this study, the potential of using hair as an alternative matrix for CYP1A2 phenotyping was 
evaluated. Paraxanthine/caffeine molar concentration ratios were determined in proximal 3-cm hair 
segments from 60 healthy volunteers and compared with reference CYP1A2 phenotyping indices 
determined in plasma. Although paraxanthine/caffeine ratios in hair and plasma overall showed a 
statistically significant correlation, large deviations in individual cases impede the interpretation of 
hair results on an individual basis. The influence of several factors on the variability between ratios in 
hair and plasma was evaluated, but, hitherto, none of these factors could explain the observed 
deviations. Therefore, hair sampling is not (yet) suitable for CYP1A2 phenotyping. 
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Tables 
Table 1. Paraxanthine/caffeine molar concentration ratios in plasma and hair samples. The median 
values together with the observed ranges are listed. 
Variable  Paraxanthine/caffeine molar 
concentration ratio in plasma 
Paraxanthine/caffeine molar 
concentration ratio in hair 
 n median range median range 
All participants 60 0.40 0.09 – 0.95 0.41 0.12 – 0.93 
Hair color      
Blond 13 0.41 0.14 – 0.95 0.37 0.12 – 0.81 
Brown 16 0.38 0.14 – 0.73 0.41 0.21 – 0.82 
Dark 15 0.42 0.12 – 0.86 0.40 0.21 – 0.93 
Black 5 0.34 0.31 – 0.40 0.47 0.34 – 0.65 
Cosmetic colouring      
Coloured 11 0.41 0.09 – 0.84 0.47 0.18 – 0.75 
Non-treated 49 0.40 0.12 – 0.95 0.40 0.12 – 0.93 
Sex      
Women 43 0.34 a,b 0.09 – 0.84 0.40 a,b 0.12 – 0.93 
Men 17 0.51 a,b 0.31 – 0.95 0.59 a,b 0.13 – 0.82 
Hormonal contraception      
Non-users 18 0.47 a 0.26 – 0.84 0.50 a 0.12 – 0.93 
Users 25 0.28 a 0.09 – 0.66 0.37 a 0.18 – 0.68 
Smoking      
Smoker 4 0.53 0.29 – 0.86 0.52 0.31 – 0.81 
Non-smoker 56 0.40 0.09 – 0.95 0.41 0.12 – 0.93 
Caffeine intake 
(consumptions/day) 
     
0 1 0.95  0.59  
1-3 23 0.45 0.09 – 0.84 0.48 0.12 – 0.75 
4-6 32 0.37 0.12 – 0.70 0.37 0.13 – 0.93 
> 7 4 0.43 0.28 – 0.86 0.43 0.19 – 0.82 
Alcohol intake 
(consumptions/week) 
     
0 7 0.50 a,b 0.40 – 0.84 0.55 0.13 – 0.75 
1-3 26 0.35 a,b 0.09 – 0.57 0.37 0.12 – 0.93 
4-6 18 0.40 0.14 – 0.73 0.46 0.21 – 0.82 
> 7 9 0.34 0.16 – 0.95 0.35 0.19 – 0.81 
Age (years)      
20-29 43 0.39 0.09 – 0.95 0.40 0.12 – 0.82 
30-39 13 0.41 0.19 – 0.84 0.41 0.13 – 0.93 
40-49 4 0.41 0.26 – 0.66 0.50 0.34 – 0.57 
a: significantly different , b: no longer significantly different when hormonal contraception users were excluded 
 
 Figures 
Fig. 1 Caffeine and paraxanthine concentrations (a-d) and paraxanthine/caffeine molar 
concentration ratios (e) in 6 consecutive 3-cm hair segments from 4 female, healthy volunteers 
 
 
 
 
 
 
 
 
 
Fig. 2 Correlation between paraxanthine/caffeine molar concentration ratios determined in 3-cm 
proximal hair segments and in plasma samples from 60 healthy volunteers. Pearson correlation 
coefficient r is displayed, together with its p-value. Subgroups (n = 15) with a good and a poor 
correlation between ratios in hair and plasma are represented by green and red dots,  respectively. 
The remaining subjects (n = 30) are represented by blue dots. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Paraxanthine/caffeine molar concentration ratios in plasma and in hair from 60 healthy 
volunteers were arbitrarily divided into 3 subgroups containing the lowest, intermediate and highest 
ratios (n = 20 for each group). A: green lines between subjects showing the lowest ratios in plasma 
and in hair (n =12), orange lines between subjects showing the lowest ratios in plasma and 
intermediate ratios in hair (n = 6), red lines between subjects showing the lowest ratios in plasma 
and highest ratios in hair (n = 2). B: green lines between subjects showing the highest ratios in 
plasma and in hair (n = 12), orange lines between subjects showing the highest ratios in plasma and 
intermediate ratios in hair (n = 5), red lines between subjects showing the highest ratios in plasma 
and lowest ratios in hair (n = 3) 
 
 
 
 
 
 
Fig. 4 Distribution of participants, sorted according to different factors (*), in the entire data set (n = 
60) and in the subgroups of subjects showing a good (n= 15) or poor correlation (n = 15) between 
ratios in hair and plasma 
(*) a: hair color (only non-cosmetically coloured samples), b: cosmetic hair colouring, c: hormonal 
contraception, d: sex, e: smoking, f: average number of caffeine consumptions per day, g: average 
number of alcohol consumptions per week, h: age 
 
 
 
 
